Frankfurt - Delayed Quote EUR

ME Therapeutics Holdings Inc. (Q9T.F)

Compare
3.3400 +0.3200 (+11.85%)
As of 8:59 AM GMT+2. Market Open.
Currency in CAD All numbers in thousands
Breakdown
TTM
8/31/2023
9/30/2022
8/31/2022
Operating Expense
1,391.3500
977.3710
295.2670
134.9840
Operating Income
-1,391.3500
-977.3710
-295.2670
-134.9840
Net Non Operating Interest Income Expense
24.4240
3.9490
-7.9760
-10.8000
Other Income Expense
--
-5,546.9680
-3,001.5260
--
Pretax Income
-3,929.5260
-6,520.3900
-3,304.7690
-145.7840
Net Income Common Stockholders
-3,929.5260
-6,520.3900
-3,304.7690
-145.7840
Diluted NI Available to Com Stockholders
-3,929.5260
-6,520.3900
-3,304.7690
-145.7840
Basic EPS
-0.16
-0.28
--
-0.01
Diluted EPS
-0.16
-0.28
--
-0.01
Basic Average Shares
25,189.4940
23,561.1050
--
23,175.7790
Diluted Average Shares
25,189.4940
23,561.1050
--
23,175.7790
Total Operating Income as Reported
-1,438.1320
-984.8330
-323.0670
-162.7840
Total Expenses
1,391.3500
977.3710
295.2670
134.9840
Net Income from Continuing & Discontinued Operation
-3,929.5260
-6,520.3900
-3,304.7690
-145.7840
Normalized Income
1,637.4420
-953.4220
-3,304.7690
-145.7840
Interest Income
24.4240
11.4110
2.8240
--
Interest Expense
--
7.4620
10.8000
10.8000
Net Interest Income
24.4240
3.9490
-7.9760
-10.8000
EBIT
-3,929.5260
-6,512.9280
-3,293.9690
-134.9840
EBITDA
-3,929.4840
-6,512.8790
-3,293.9080
-134.9230
Reconciled Depreciation
0.0420
0.0490
0.0610
0.0610
Net Income from Continuing Operation Net Minority Interest
-3,929.5260
-6,520.3900
-3,304.7690
-145.7840
Total Unusual Items Excluding Goodwill
-5,566.9680
-5,566.9680
--
--
Total Unusual Items
-5,566.9680
-5,566.9680
--
--
Normalized EBITDA
1,637.4840
-945.9110
-3,293.9080
-134.9230
8/31/2022 - 12/11/2023

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers